title: Vibro-acoustic stimulation does not alter the duration of high and low fetal heart rate variability episodes.
abstract: To study the effect of vibro-acoustic stimulation on high and low fetal heart rate (FHR) variability episodes. Prospective control study, in 21 high risk pregnancies between 32 to 39 weeks gestation. FHR pattern was recorded with cardiotocograph (CTG). After 5 min low FHR variability a vibro-acoustic stimulator was activated in contact with or above the maternal abdomen (sham) on a random basis on two consecutive days, and CTG was continued to obtain a complete high and low FHR variability cycle. Complete high and low FHR variability cycles were obtained in 12 patients with mean recording time of 129.5 minutes (range 69-185 min). The mean baseline FHR increased by 32.5 +/- 9.4 bpm after contact vibro-acoustic stimulation, but remained unchanged after sham stimulation. Mean duration of high FHR variability was 56.6 +/- 32.9 min and 47.3 +/- 23.7 min, respectively, and mean duration of the consecutive low FHR variability episode was similar after contact and sham stimulation. The complete cycles were 71.1 +/- 34.7 min and 66.2 +/- 21.2 min, respectively. Vibro-acoustic stimulation induced an abrupt change from low to high FHR variability, but the complete cycle of high and low FHR variability was not altered, when compared with the corresponding cycle following sham stimulation on the same fetus.
authors: Department of Obstetrics and Gynaecology, National University Hospital, National University Singapore.
authors: S
authors: S
authors: Montan
authors: S
authors: S
authors: Arulkumaran
authors: M
authors: M
authors: Nyman
authors: S S
authors: SS
authors: Ratnam
mesh_terms: D000161:Acoustic Stimulation / Q000009:adverse effects*; D000328:Adult; D001519:Behavior / Q000502:physiology; D005260:Female; D005324:Fetal Movement / Q000502:physiology; D006340:Heart Rate, Fetal / Q000502:physiology*; D006801:Humans; D011247:Pregnancy; D013610:Tachycardia / Q000209:etiology; D014732:Vibration / Q000009:adverse effects*